NCDEU is a scientific meeting that focuses on the latest developments in psychopharmacologic clinical trials research and related methodology. Co-sponsored by NIMH and the American Society of Clinical Psychopharmacology (ASCP), the meeting brings together over 1200 academic and industry investigators, research pharmacists, and clinicians and provides state-of-the-art workshops, panels, posters, and other special sessions devoted to advancing clinical research. Through its highly successful New Investigator Program, NCDEU emphasizes the development of research careers for those relatively new to the field of clinical research.